Compare Smith & Nephew plc (SNN) vs Sempra Energy (SRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Sempra Energy — how do they compare? Smith & Nephew plc trades at $27.21 (market cap $11.10B), while Sempra Energy trades at $81.32 (market cap $52.36B). The key difference: Sempra Energy is far larger — about 4.7× Smith & Nephew plc's market cap, and Sempra Energy pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and Sempra Energy for 9 Days on average.
| SNN | SRE | |
|---|---|---|
Market Cap | $11.10B | $52.36B |
Volume | 1,051,703 | 3,338,383 |
Sector | Health | Utilities |
52-Week High | $37.17 | $99.75 |
52-Week Low | $26.42 | $76.90 |
Typical Hold Time | 121 Days | 9 Days |
Enterprise Value | $14.13B | $89.00B |
Dividend Yield | 2.95% | 3.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNN trades at $27.10, near its 52-week low, with a bearish technical signal. The company reported solid fundamentals with revenue growth to $6.16B in 2025 and a net income margin of 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. Cash flow from operations remains strong at $1.29B, though net cash flow was negative $64M in 2025.
The outlook is mixed: strong profitability and innovation support long-term value, but near-term headwinds include analyst downgrades and competitive pressures. Risks involve execution challenges and market sentiment. The stock presents a cautious opportunity for value investors, balancing solid fundamentals against current bearish trends.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Sempra Energy
Sempra is an energy infrastructure company with regulated utility and energy network businesses. Its operations include electric and gas utilities as well as energy infrastructure in North America.
Read more on SRE →
